Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.756672
Abstract: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality worldwide. Patients with early-stage HCC can be treated successfully with surgical resection or liver transplantation. However, the usual late diagnosis of HCC precludes curative… read more here.
Keywords: treatment clinical; cabozantinib hcc; hcc; treatment ... See more keywords